Virtual Cognitive Behavioural Therapy for Psychosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if virtual cognitive behavioral therapy (CBT) can assist individuals with schizophrenia-spectrum disorders who are currently experiencing active psychosis symptoms. Participants will either receive six months of virtual CBT sessions or continue with their usual care. Virtual CBT includes one-on-one sessions with a therapist via Zoom, and all necessary technology will be provided if needed. This trial suits those who have schizophrenia or a similar condition, are currently experiencing active symptoms, and can use a computer. As an unphased trial, this study offers the opportunity to explore innovative therapy options and contribute to advancing mental health treatments.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that Virtual Cognitive Behavioural Therapy for Psychosis is safe?
Research has shown that cognitive behavioral therapy for psychosis (CBTp) is safe. Studies have found it helps with symptoms such as hallucinations and delusions. Even when delivered online, it remains effective and well-received by most patients. One study noted that a few participants discontinued the online therapy early, but most completed their sessions without issues. This suggests that online CBTp is generally manageable. Overall, evidence supports its safety and acceptability for individuals experiencing active symptoms of psychosis.12345
Why are researchers excited about this trial?
Virtual Cognitive Behavioural Therapy for Psychosis is unique because it delivers therapy directly to patients' homes using an online platform. This approach ensures accessibility for individuals who may have difficulty attending in-person sessions. Additionally, it supplements the standard care without requiring any changes to existing treatments, which could make it a versatile option for patients. Researchers are excited about this method as it combines the effectiveness of Cognitive Behavioural Therapy with the convenience of virtual delivery, potentially reaching a broader audience and improving adherence to mental health treatment.
What evidence suggests that Virtual Cognitive Behavioural Therapy is effective for psychosis?
Research has shown that Cognitive Behavioral Therapy for psychosis (CBTp) can improve symptoms in individuals with schizophrenia-related disorders. Studies have found that CBTp helps manage symptoms like hallucinations and delusions and teaches coping skills. A review of several studies found that CBTp has a noticeable impact, though it might not work for everyone. In this trial, participants will receive Virtual CBT for Psychosis through video calls, enabling participation from home. Overall, evidence suggests that Virtual CBT for Psychosis can effectively manage symptoms of psychosis.16789
Who Is on the Research Team?
Michael W Best, PhD
Principal Investigator
University of Toronto
Are You a Good Fit for This Trial?
This trial is for individuals aged 18-65 with active symptoms of psychosis, who can use a computer and communicate in English. It's suitable for those diagnosed with schizophrenia or related psychotic disorders, provided they're not abusing substances or have had CBT in the last 6 months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive individual virtual cognitive behavioural therapy sessions for 1-hour per week for 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Virtual Cognitive Behavioural Therapy for Psychosis
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Toronto
Lead Sponsor
Ontario Shores Centre for Mental Health Sciences
Collaborator